Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Pomdoctor Limited (NASDAQ: POM) and reminds investors of the April 13, 2026 deadline to seek the role of lead plaintiff in a federal securities class action filed against the company [1] Group 1: Allegations Against Pomdoctor - The complaint alleges that Pomdoctor and its executives violated federal securities laws by making false and/or misleading statements and failing to disclose critical information [1] - Specific allegations include involvement in a fraudulent stock promotion scheme, use of offshore accounts for share dumping, and omission of false rumors affecting stock price [1] - The company's public statements were deemed materially misleading and lacked a reasonable basis due to these omissions [1] Group 2: Stock Performance - Pomdoctor's share price experienced a significant decline from approximately $0.50 per share on December 10, 2025, to about $0.38 per share on December 11, 2025, marking a decline of roughly $0.12 per share or approximately 24% in a single trading session [1] - This decline followed increased volatility and selling pressure amid broader investor concerns regarding Pomdoctor's financial performance and valuation [1] Group 3: Legal Proceedings - The court-appointed lead plaintiff is defined as the investor with the largest financial interest in the relief sought by the class, who will oversee the litigation on behalf of the class members [1] - Any member of the putative class may move the Court to serve as lead plaintiff or choose to remain an absent class member without affecting their ability to share in any recovery [1]
POM SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Pomdoctor (POM) Investors of Securities Class Action Deadline on April 13, 2026